This report reviews open-label randomized and non-randomized experimental studies as well as observational studies of harm associated with the Janus kinase inhibitors (JAKi) tofacitinib and upadacitinib for the rheumatic conditions psoriatic arthritis, ankylosing spondylitis and...
This report reviews open-label randomized and non-randomized experimental studies as well as observational studies of harm associated with the Janus kinase inhibitors (JAKi) tofacitinib and upadacitinib for ulcerative colitis in the post authorization time period. Click...
This report is a systematic review of tofacitinib for the treatment of adult patients with ankylosing spondylitis. Tofacitinib is a Janus kinase inhibitor (JAKi), a type of anti-inflammatory rheumatic drug. It blocks the activity of...
This report is a systematic review of tofacitinib for the treatment of adult patients with psoriatic arthritis. Tofacitinib is a Janus kinase inhibitor (JAKi), a type of anti-inflammatory rheumatic drug. It blocks the activity of...